These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 12913399)
1. Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials. Bertram U; Moser M; Peter K; Kuecherer HF; Bekeredjian R; Straub A; Nordt TK; Bode C; Ruef J J Thromb Thrombolysis; 2002 Dec; 14(3):197-203. PubMed ID: 12913399 [TBL] [Abstract][Full Text] [Related]
6. Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment. Tcheng JE Am J Cardiol; 1999 May; 83(9A):7E-11E. PubMed ID: 10357575 [No Abstract] [Full Text] [Related]
7. Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond. Giordano A; Musumeci G; D'Angelillo A; Rossini R; Zoccai GB; Messina S; Coscioni E; Romano S; Romano MF Curr Drug Metab; 2016; 17(2):194-203. PubMed ID: 26652157 [TBL] [Abstract][Full Text] [Related]
9. Platelet glycoprotein IIb/IIIa blockade with tirofiban: effect on aggregation caused by P256, an antibody to human IIb/IIIa receptors. Fisher I; Robinson P; Ritter JM Br J Clin Pharmacol; 1999 Aug; 48(2):197-9. PubMed ID: 10417496 [TBL] [Abstract][Full Text] [Related]
10. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions. Leclerc JR Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256 [TBL] [Abstract][Full Text] [Related]
11. Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists. Ilveskero S; Lassila R Thromb Res; 2006; 117(3):291-7. PubMed ID: 15878612 [TBL] [Abstract][Full Text] [Related]
12. Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates. Moser M; Bertram U; Peter K; Bode C; Ruef J J Cardiovasc Pharmacol; 2003 Apr; 41(4):586-92. PubMed ID: 12658060 [TBL] [Abstract][Full Text] [Related]
13. Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Kereiakes DJ; Broderick TM; Roth EM; Whang D; Shimshak T; Runyon JP; Hattemer C; Schneider J; Lacock P; Mueller M; Abbottsmith CW Am J Cardiol; 1999 Aug; 84(4):391-5. PubMed ID: 10468074 [TBL] [Abstract][Full Text] [Related]
14. Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregation. Frelinger AL; Furman MI; Barnard MR; Krueger LA; Dae MW; Michelson AD Am J Cardiol; 2003 Nov; 92(9):1099-101. PubMed ID: 14583364 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Nannizzi-Alaimo L; Alves VL; Phillips DR Circulation; 2003 Mar; 107(8):1123-8. PubMed ID: 12615789 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban. Kereiakes DJ; Lorenz T; Young JJ; Kukielka G; Mueller MN; Nanniazzi-Alaimo L; Phillips DR J Thromb Thrombolysis; 2001 Oct; 12(2):123-7. PubMed ID: 11729363 [TBL] [Abstract][Full Text] [Related]
17. Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention. Day JR; Malik IS; Weerasinghe A; Poullis M; Nadra I; Haskard DO; Taylor KM; Landis RC Heart; 2004 Jul; 90(7):794-9. PubMed ID: 15201252 [TBL] [Abstract][Full Text] [Related]
18. Current issues with glycoprotein IIb-IIIa antagonists. Schneider DJ Curr Drug Targets; 2011 Nov; 12(12):1813-20. PubMed ID: 21718238 [TBL] [Abstract][Full Text] [Related]
19. Abciximab pharmacodynamics are unaffected by antecedent therapy with other GPIIb/IIIa antagonists in non-human primates. Nakada MT; Sassoli PM; Tam SH; Nedelman MA; Jordan RE; Kereiakes DJ J Thromb Thrombolysis; 2002 Aug; 14(1):15-24. PubMed ID: 12652146 [TBL] [Abstract][Full Text] [Related]
20. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. Adgey AA Am Heart J; 1998 Apr; 135(4):S43-55. PubMed ID: 9539495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]